Drugs / progenipoietin
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT00005841 | Jun → Dec 2000 | cutaneous melanoma, ocular melanoma | University of Southern California | Terminated | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | progenipoietin | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00005841 ↗ |
| Known as | SD-9427 | “A phase I trial of SD-9427 (progenipoietin) with a multipeptide vaccine for resected metastatic melanoma.” PMID 12684398 ↗ Apr 2003 |
| Action | Activate | “SD-9427 (progenipoietin), an agonist of granulocyte colony-stimulating factor and the FLT-3 receptor” PMID 12684398 ↗ Apr 2003 |